Dorman Products (NASDAQ: DORM) reported Q4 EPS of $2.17, $0.05 better than the analyst estimate of $2.12. Revenue for the quarter came in at $537.9 million versus the consensus estimate of $573.38 million.

GUIDANCE:

Dorman Products sees FY2026 EPS of $8.10-$8.50, versus the consensus of $9.45.

For earnings history and earnings-related data on Dorman Products (DORM) click here.